July 2023 Newsletter

One of the most commonly used features to set a physician/patient follow-up order in CRStar is to set the order on the diagnosis screen when entering the Care Team. Utilizing CRStar’s Follow-Up Template feature can assist users in standardizing follow-up processes, therefore increasing efficiency.

Making use of this feature allows the user to default certain types of follow-up contacts on the outcome screen without needing to search for individual names. Additionally, this feature allows users to default certain letter types for each contact.

When users are abstracting cases, the “Default Letter Type” feature can be used to set a pre-defined template. Users may create as many templates as needed. Note: Up to four contacts can be used when creating each template.

The illustration above shows three examples of templates, each utilizing various letter types. To set up a template, go to the System Management Module, then select "Follow Up Order."

For detailed instructions, please refer to the CRStar User Manual located on the Resource Page. If assistance is needed, our support team will be happy to assist.

The most common adult primary intracranial neoplasms are meningiomas. The age-adjusted incidence of meningiomas reported in the United States is 12 per 100,000 women per year and it continues to increase, according to the Central Brain Tumor Registry of the United States.

Since many of our cancer registries collect meningiomas and include them as a class of case 60, I thought the recent finding of association between meningiomas and breast cancer was important (Degeneffe A, et al., The association between meningioma and breast cancer: A systematic review and meta-analysis. JAMA Network Open. 2023;6(6), doi:10.1001/jamanetworkopen).

A systematic literature search was performed up to April 2023 to identify articles showing an association of meningioma with breast cancer. All studies reporting women diagnosed with meningioma and breast cancer were identified.

Thirteen studies revealed a significantly greater prevalence of breast cancer in female patients with meningioma than in the overall population (odds ratio [OR], 9.87; 95%CI, 7.31-13.32). This large systematic review on the association between meningioma and breast cancer found a nearly 10-fold higher odds of breast cancer in female patients with meningioma compared with the general female population.

Further research is required to identify the factors causing this association. Obviously, this information is important for breast cancer screening studies and supports the concept of collecting certain benign tumors in our registries.

The integration of data to and from the cancer registry can add a tremendous amount of value to any cancer program, therefore, impacting the patient journey. A few of the value adds include:

• Promotes concurrency of casefinding and abstracting
• Increases follow-up rates
• Increases registry productivity and efficiency
• Adjusts resources for other cancer registry operations
• Promotes concurrent reporting, quality and research initiaves
• Supports the needs of the entire oncology service line

 Registries nationwide are using one or more data sources for casefinding, abstracting and follow-up, as well as sharing data with other sources. Automating data eliminates the need for manual processes and the data can be imported or exported in real-time or at pre-scheduled Intervals. The table below lists both inbound and outbound sources for cancer registry data integration.

If your registry would like to maximize the value of the registry data and learn more about

integrating with other oncology partners, click on the Let’s Talk button to schedule a one-on-one discussion with Melanie Rogan, Director, Growth and Strategic Services.

The latest episode of the Cancer Registry World podcast is available now! Guest Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director of AONN+, joins Dr. Frederick L. Greene to discuss the role of the oncology nurse and patient navigator. Our discussion also provides valuable tips for navigation research utilizing the cancer registry.

Previous episodes with guests Kay Washington, Lori A. Swain, Loria A. Pollack, Shirley Dalrymple, Robert K. Brookland, Timothy W. Mullett, Catherine Bieker, Jon Patrick, Barbara Dearmon, Lejla Hadzikadic-Gusic, William Laffey, Rohit Nayak, Mellisa Wheeler, Lillie D. Shockney, and Karen Mason, are still available on our website or wherever you listen to your favorite podcasts, including ApplePodcasts, Spotify, Stitcher, iHeartRadio and TuneIn.

The US Cancer Statistics were recently released by the CDC.

The top ten cancers of new cancer cases are shown below.

The data is from 2020 and includes both male and females, as well as all races and ethnicities. How does the data from your health system measure up?

A quick report to find your facility’s top 10 sites can easily be created in CRStar by using the Ad hoc Graph for a Population. This is a great comparison to share with administration and the entire oncology service line.

Do you love CRStar?

So do we and we are offering our loyal customers the chance to earn a $200 gift card when a Cancer Program that you refer becomes an ERS customer!

Please click "Refer CRStar" below if you know of any Cancer Programs that could benefit from CRStar and the advantages that CRStar users enjoy and rely on.

Let's grow our CRStar community together!

Terms and conditions can be found on the CRStar Referral Form.

View a CRStar video

Read user stories

Visit our website

ERS, Inc. | www.mycrstar.com